Journal Information
Vol. 161. Issue 5.
Pages 185-191 (September 2023)
Vol. 161. Issue 5.
Pages 185-191 (September 2023)
Original article
Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19
Valor del aumento del biomarcador supresor soluble de tumorigenicidad 2 (sST2) al ingreso como indicador de gravedad en pacientes con COVID-19
María Arnaldos-Carrillo, José Antonio Noguera-Velasco, Isabel M. Martínez-Ardil, Alejandro Riquelme-Pérez, Iria Cebreiros-López, Álvaro Hernández-Vicente, José Antonio Ros-Lucas, Amjad Khan, Antoni Bayes-Genís, Domingo Pascual-Figal
Article information
These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscribe
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail